BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 18440212)

  • 21. [Validation and regulatory acceptance of alternative methods for toxicity evaluation].
    Ohno Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2004; (122):1-9. PubMed ID: 15940895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proposal to improve vertebrate cell cultures to establish them as substitutes for the regulatory testing of chemicals and effluents using fish.
    Schirmer K
    Toxicology; 2006 Jul; 224(3):163-83. PubMed ID: 16765501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OECD ist accepting test guidelines for validated in vitro toxicity tests in 1996.
    Spielmann H; Reinhardt C
    ALTEX; 1996; 13(4):167-174. PubMed ID: 11178458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FRAME Annual Lecture. International co-operation: an essential requirement for replacing animal toxicity tests.
    Spielmann H
    Altern Lab Anim; 2001; 29(6):637-46; discussion 647-8. PubMed ID: 11709040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Collaboration between ZEBET, FRAME, and ECVAM: FRAME's contribution to establishing the Three Rs in Europe.
    Spielmann H
    Altern Lab Anim; 2009 Dec; 37 Suppl 2():23-7. PubMed ID: 20105007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated decision-tree testing strategies for developmental and reproductive toxicity with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Feb; 36(1):65-80. PubMed ID: 18333715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction and replacement of animal tests required in standards for safety testing.
    Zarnow K; Spielmann H
    ALTEX; 1998; 15(3):129-140. PubMed ID: 11178511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Replacement, reduction or refinement of animal use in the quality control of veterinary vaccines: development, validation and implementation.
    van der Kamp MD
    Dev Biol Stand; 1996; 86():73-6. PubMed ID: 8785994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of the status of alternative approaches to animal testing and the development of integrated testing strategies for assessing the toxicity of chemicals under REACH--a summary of a DEFRA-funded project conducted by Liverpool John Moores University and FRAME.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():149-58. PubMed ID: 16555968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternatives to animal experimentation: the regulatory background.
    Garthoff B
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):388-92. PubMed ID: 15982684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral acute toxic class method: a successful alternative to the oral LD50 test.
    Schlede E; Genschow E; Spielmann H; Stropp G; Kayser D
    Regul Toxicol Pharmacol; 2005 Jun; 42(1):15-23. PubMed ID: 15896439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of alternative methods.
    Goldberg AM
    J Toxicol Sci; 1995 Sep; 20(4):443-9. PubMed ID: 8531238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation.
    Höfer T; Gerner I; Gundert-Remy U; Liebsch M; Schulte A; Spielmann H; Vogel R; Wettig K
    Arch Toxicol; 2004 Oct; 78(10):549-64. PubMed ID: 15170526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternatives to animal testing: research, trends, validation, regulatory acceptance.
    Huggins J
    ALTEX; 2003; 20(Suppl 1):3-61. PubMed ID: 14671702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ["Replacement Methods to Animal Testing" as the incentive topic of the German Ministry of Education and Research. Selected results on biological drugs].
    Diekmann W; Hansper M
    ALTEX; 2001; 18(1):23-8. PubMed ID: 11248846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation and regulatory acceptance of new carcinogenicity tests.
    Spielmann H
    Toxicol Pathol; 2003; 31(1):54-9. PubMed ID: 12597449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative methods to safety studies in experimental animals.
    Greim HA
    Arch Toxicol; 2009 Jan; 83(1):5-7. PubMed ID: 19034432
    [No Abstract]   [Full Text] [Related]  

  • 38. Toxicology in the 21st century--working our way towards a visionary reality.
    Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
    Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replacement of in vivo acute oral toxicity studies by in vitro cytotoxicity methods: opportunities, limits and regulatory status.
    Ukelis U; Kramer PJ; Olejniczak K; Mueller SO
    Regul Toxicol Pharmacol; 2008 Jun; 51(1):108-18. PubMed ID: 18362045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 4R concept for the safety testing of immunobiologicals.
    Cussler K
    Dev Biol Stand; 1999; 101():121-6. PubMed ID: 10566784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.